---
title: Improve walking mobility using exoskeleton
nct_id: NCT06028529
phase: NA
status: RECRUITING
sponsor: VA Office of Research and Development
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06028529"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06028529"
last_fetched: "2026-05-10T14:07:26.416Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking mobility using exoskeleton

**Goal (in five words):** Improve walking mobility using exoskeleton

**Official Title:** Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease

**Trial ID:** [NCT06028529](https://clinicaltrials.gov/study/NCT06028529)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** VA Office of Research and Development
- **Target Enrollment:** 30 participants
- **Start Date:** 2024-09-01
- **Completion Date:** 2026-08-31
- **Conditions:** Parkinson's Disease
- **Interventions:** Exoskeleton
- **Intervention Types:** DEVICE

## Summary For Families

Goal: to see if a portable robotic exoskeleton can be worn safely and help people with Parkinson's improve walking, balance, and overall mobility. Approach: participants wear a wearable device (Keeogo) that actively assists hip and knee flexion and extension during walking, reducing effort and stabilizing steps, and it augments movement without changing Parkinson's medications like levodopa. Eligibility: veterans aged 18 to 90 with Parkinson's confirmed by a PADRECC specialist, modified Hoehn and Yahr stage II to V, who can attend visits at the Richmond VA and pass basic strength and walking screens. Key exclusions include severe heart or lung disease, significant dementia (MoCA under 17), very low bone density, lower limb amputation, certain implants, or body size outside 5'1",6'3" and over 250 pounds.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 90 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* PD confirmed by a PADRECC movement disorder specialist using UK Brain Bank Criteria
* Modified H\&Y stage II-V
* Veteran
* Able to attend visits at the Richmond VA Medical Center

Exclusion Criteria:

* neurological, musculoskeletal, or other disorders unrelated to PD contributing to impairment of stance, gait, balance or coordination
* severe CHF, COPD, or those requiring nasal canula O2
* history of implantable cardiac device or ablative surgery
* moderately-severe to severe cognitive impairment / dementia (Montreal Cognitive Assessment \< 17/30)
* symptomatic orthostatic hypotension with exertion
* feeding tube or associated port placement (PEG/J-PEG)
* body height less than 5'1" or greater than 6'3"
* body weight greater than 250 pounds
* amputation of any portion of the lower limbs
* osteoporosis as defined by DEXA Scan T score \< -2.5
* failure to meet B-Temia-established hip and knee flexion and extension manual muscle test (MMT) prerequisite screening parameters, which assure that individuals can adequately engage and walk against the resistive forces of the Keeogo
* inability to complete 20 minutes of walking with the exoskeleton (over a maximum period of one hour) at the initial screening/testing session
```

## Locations (1)

- Richmond VA Medical Center, Richmond, VA, Richmond, Virginia, United States _(37.5538, -77.4603)_
  - Amanda O Hill — (CONTACT) — 804-675-5151 — Amanda.Hill3@va.gov
  - Alyssa Huizar — (CONTACT) — (804) 675-5151 — alyssa.huizar@va.gov
  - Jessica B Lehosit — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Rachel G Sinclair, MPHA — (CONTACT) — (804) 675-5931 — rachel.sinclair@va.gov
- Jessica B Lehosit — (CONTACT) — (804) 675-5000 — jessica.lehosit@va.gov

---

*Canonical: https://parkinsonspathways.com/trial/NCT06028529*  
*HTML version: https://parkinsonspathways.com/trial/NCT06028529*  
*Source data: https://clinicaltrials.gov/study/NCT06028529*